<--- Back to Details
First PageDocument Content
Biology / Hypoglycemia / Lorazepam / Insulin-like growth factor 1 / Tercica / Growth hormone deficiency / Oprelvekin / Chemistry / Lactams / Medicine
Date: 2011-03-04 08:08:08
Biology
Hypoglycemia
Lorazepam
Insulin-like growth factor 1
Tercica
Growth hormone deficiency
Oprelvekin
Chemistry
Lactams
Medicine

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INCRELEX® safely and effectively. See full prescribing information for INCRELEX®. INCRELEX® (mecasermin [rDNA ori

Add to Reading List

Source URL: www.accessdata.fda.gov

Download Document from Source Website

File Size: 267,51 KB

Share Document on Facebook

Similar Documents

PRIOR AUTHORIZATION POLICY Increlex® (mecasermin [rDNA origin] injection Tercica)  TO INITIATE A COVERAGE REVIEW, CALL[removed]

PRIOR AUTHORIZATION POLICY Increlex® (mecasermin [rDNA origin] injection Tercica) TO INITIATE A COVERAGE REVIEW, CALL[removed]

DocID: rxAD - View Document

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INCRELEX® safely and effectively. See full prescribing information for INCRELEX®. INCRELEX® (mecasermin [rDNA ori

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INCRELEX® safely and effectively. See full prescribing information for INCRELEX®. INCRELEX® (mecasermin [rDNA ori

DocID: gSkB - View Document

C:�a�Documents�ropin�ropin NOV draft.doc

C:aDocumentsropinropin NOV draft.doc

DocID: eWqG - View Document